The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Autoimmune Hepatitis in Childhood: A 20–Year Experience
Abstract
To determine the clinical, biochemical, and histological features, and outcome of childhood autoimmune hepatitis (AIH), we reviewed the medical records of 52 children with AIH, 32 (median age: 10 [2–15] years) anti–nuclear and/or smooth muscle antibody (ANA/SMA) positive, 20 (7 [0.8–14] years) liver/kidney microsomal antibody (LKM–1) positive, with median follow–up of 5 years (range 0.3–19). At presentation: 56% had symptoms of prolonged acute hepatitis; LKM–1 positive were younger (P = .011), with higher bilirubin (P = .007), and AST (P = .047); ANA/SMA positive had lower albumin (P = .023); 69% ANA/SMA positive, and 38% LKM–1 positive were cirrhotic (P = .080). ANA/SMA positive had increased frequency of HLA haplotype A1/B8/DR3/DR52a compared with controls (53% vs. 14%, P < .001). Of six (5 LKM–1 positive) with fulminant hepatitis, four were transplanted, one died, and one ANA/SMA positive improved with immunosuppression. Of 47 treated with immunosuppression, 2 (1 LKM–1 positive) died with no remission and 4 (2 LKM–1 positive) were transplanted 8 to 14 years after diagnosis. Immunosuppression was stopped successfully in 19% of ANA/SMA positive after a median of 3 years of treatment, but in none of LKM–1 positive. Baseline bilirubin and international normalized prothrombin ratio (INR) were independent variables predictive of outcome. In conclusion, ANA/SMA positive and LKM–1 positive AIH in childhood have clinical, biochemical, and histological differences, but similar severity and long–term outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification of chronic hepatitis: Diagnosis, grading and staging
Desmet, V. J., Gerber, M., Hoofnagle, J. H., Manns, M., & Scheuer, P. J. (1994) · Hepatology · doi:10.1002/hep.1840190629 · Cited by 2,593
Microdroplet Assay of Human Serum Cytotoxins
TERASAKI, P. I., & McCLELLAND, J. D. (1964) · Nature · doi:10.1038/204998b0 · Cited by 2,060
Homberg, J.-C., Abuaf, N., Bernard, O., Islam, S., Alvarez, F., Khalil, S. H., Poupon, R., Darnis, F., Lévy, V.-G., Grippon, P., et al. (1987) · Hepatology · doi:10.1002/hep.1840070626 · Cited by 576
Donaldson, P. T., Doherty, D. G., Hayllar, K. M., McFarlane, I. G., Johnson, P. J., & Williams, R. (1991) · Hepatology · doi:10.1002/hep.1840130415 · Cited by 389
Self-citationAzathioprine for Long-Term Maintenance of Remission in Autoimmune Hepatitis
Johnson, P. J., McFarlane, I. G., & Williams, R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510123331502 · Cited by 382
Doherty, D. G., Donaldson, P. T., Underhill, J. A., Farrant, M. J., Duthie, A., Mieli-Vergani, G., McFarlane, I. G., Johnson, P. J., Eddleston, A. L. W. F., Mowat, A. P., et al. (1994) · Hepatology · doi:10.1002/hep.1840190311 · Cited by 219
Self-citationAntibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis
Czaja, A. J., Carpenter, H. A., & Manns, M. P. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90160-e · Cited by 155
Primary sclerosing cholangitis in childhood
Ricketts, R. R. (1988) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(88)80783-8 · Cited by 132
Immunogenetics of chronic liver diseases
Manns, M. P., & Krüger, M. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90427-8 · Cited by 131
Autoimmune Hepatitis Associated with Anti-Actin Antibodies in Children and Adolescents
Maggiore, G., Veber, F., Bernard, O., Hadchouel, M., Homberg, J. C., Álvarez, F., Hadchouel, P., & Alagille, D. (1993) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-199311000-00007 · Cited by 126
Cited by
Alvarez, F., Berg, P. A., Bianchi, F. B., Bianchi, L., Burroughs, A. K., Cancado, E. L., Chapman, R. W., Cooksley, W. G. E., Czaja, A. J., Desmet, V. J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80297-9 · Cited by 2,903
Self-citationDiagnosis and management of autoimmune hepatitis
Manns, M. P., Czaja, A. J., Gorham, J. D., Krawitt, E. L., Mieli-Vergani, G., Vergani, D., & Vierling, J. M. (2010) · Hepatology · doi:10.1002/hep.23584 · Cited by 1,442
Self-citationEASL Clinical Practice Guidelines: autoimmune hepatitis
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.030 · Cited by 1,245
Mack, C. L., Adams, D., Assis, D. N., Kerkar, N., Manns, M. P., Mayo, M. J., Vierling, J. M., Alsawas, M., Murad, M. H., & Czaja, A. J. (2020) · Hepatology · doi:10.1002/hep.31065 · Cited by 983
“In type 1 AIH, persistent production of SMA or antiactin in the setting of biochemical remission have been associated with histological features of active liver inflammation.”
BackgroundInfluentialSquires, R. H., Shneider, B. L., Bucuvalas, J., Alonso, E., Sokol, R. J., Narkewicz, M. R., Dhawan, A., Rosenthal, P., Rodriguez-Baez, N., Murray, K. F., et al. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.12.051 · Cited by 868
Krawitt, E. L. (2006) · New England Journal of Medicine · doi:10.1056/nejmra050408 · Cited by 753
Gregorio, G. (2001) · Hepatology · doi:10.1053/jhep.2001.22131 · Cited by 692
“Median follow-up time was 7 (2-16) years (ASC: 6 [2-16] vs.”
BackgroundSelf-citationDiagnosis and treatment of autoimmune hepatitis
Czaja, A. J., & Freese, D. K. (2002) · Hepatology · doi:10.1053/jhep.2002.34944 · Cited by 563
Vergani, D., Alvarez, F., Bianchi, F. B., Cançado, E. L. R., Mackay, I. R., Manns, M. P., Nishioka, M., & Penner, E. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.002 · Cited by 446
Self-citationMieli-Vergani, G., Vergani, D., Czaja, A. J., Manns, M. P., Krawitt, E. L., Vierling, J. M., Lohse, A. W., & Montano-Loza, A. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.17 · Cited by 425
Self-citationDe-novo autoimmune hepatitis after liver transplantation
Kerkar, N., Hadzic, N., Davies, E. T., Portmann, B., Donaldson, P. T., Rela, M., Heaton, N. D., Vergani, D., & Mieli-Vergani, G. (1998) · The Lancet · doi:10.1016/s0140-6736(97)06478-7 · Cited by 413
Self-citationImpairment of CD4+CD25+ regulatory T-cells in autoimmune liver disease
Longhi, M. S., Ma, Y., Bogdanos, D. P., Cheeseman, P., Mieli-Vergani, G., & Vergani, D. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.03.008 · Cited by 405
Self-citationMieli‐Vergani, G., Vergani, D., Baumann, U., Czubkowski, P., Debray, D., Dezsofi, A., Fischler, B., Gupte, G., Hierro, L., Indolfi, G., et al. (2018) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001801 · Cited by 356
Self-citationFunctional Study of CD4+CD25+ Regulatory T Cells in Health and Autoimmune Hepatitis
Longhi, M. S., Hussain, M. J., Mitry, R. R., Arora, S. K., Mieli-Vergani, G., Vergani, D., & Ma, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4484 · Cited by 323
Self-citationAdvances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis
Czaja, A. J., & Manns, M. P. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.053 · Cited by 280
Heneghan, M. A., Yeoman, A. D., Verma, S., Smith, A. D., & Longhi, M. S. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62163-1 · Cited by 277
Ma, Y., Okamoto, M., Thomas, M. G., Bogdanos, D. P., Lopes, A. R., Portmann, B., Underhill, J., Dürr, R., Mieli-Vergani, G., & Vergani, D. (2002) · Hepatology · doi:10.1053/jhep.2002.32092 · Cited by 271
Self-citationSquires, R. H., Ng, V., Romero, R., Ekong, U., Hardikar, W., Emre, S., & Mazariegos, G. V. (2014) · Hepatology · doi:10.1002/hep.27191 · Cited by 254
Deneau, M., Jensen, K. M., Holmen, J., Williams, M. S., Book, L. S., & Guthery, S. L. (2013) · Hepatology · doi:10.1002/hep.26454 · Cited by 233
Prediction of short- and long-term outcome in patients with autoimmune hepatitis
Kirstein, M. M., Metzler, F., Geiger, E., Heinrich, E., Hallensleben, M., Manns, M. P., & Vogel, A. (2015) · Hepatology · doi:10.1002/hep.27983 · Cited by 136
Review article: overlap syndromes and autoimmune liver disease
Trivedi, P. J., & Hirschfield, G. M. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05223.x · Cited by 126
Autoimmune hepatitis and its variant syndromes
BEN-ARI, Z., & CZAJA, A. J. (2001) · Gut · doi:10.1136/gut.49.4.589 · Cited by 102
Terziroli Beretta-Piccoli, B., Mieli-Vergani, G., & Vergani, D. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.10.004 · Cited by 61
Self-citation“Autoimmune(-Like)” drug and herb induced liver injury: new insights into molecular pathogenesis
Sebode, M., Schulz, L., & Lohse, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091954 · Cited by 47
Seamless management of juvenile autoimmune liver disease: long-term medical and social outcome
Di Giorgio, A., Hadzic, N., Dhawan, A., Deheragoda, M., Heneghan, M. A., Vergani, D., Mieli-Vergani, G., & Samyn, M. (2020) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2019.11.028 · Cited by 44
Self-citation
Metadata
- Authors
- Gregorio, G. V., Portmann, B., Reid, F., Donaldson, P. T., Doherty, D. G., McCartney, M., Mowat, A. P., Vergani, D., & Mieli-Vergani, G.
- Venue
- Hepatology
- Published
- 1997-03
- Volume
- 25
- Issue
- 3
- Pages
- 541-547
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2160126419
- Cited by
- 665
- References
- 20
- FWCI
- 6.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.